Preclinical studies have also revealed that dual agonists of GLP-1R and glucose-dependent insulinotropic polypeptide receptor (GIPR) have synergistic anti-inflammatory and neuroprotective effects, suggesting the potential advantages of multitargeting strategies (Yuan et al., 2024)
They conclude: Given the severe societal, familial, and economic burden of diabetes-related dementia, these findings raise important considerations about the role of GLP-1 [receptor agonists] as first-line therapies in [type 2 diabetes] management
Methionine deficiency can lead to decreased muscle mass and difficulty building muscle
Mechanism of action: GLP-1 receptor agonists work through multiple physiological pathways
In Sri Lanka, progressive tone clarification usually requires multiple sessions
Gruber A, Horwood F, Sithole J, Ali NJ, Idris I